Autolus Therapeutics (AUTL)
(Real Time Quote from BATS)
$3.50 USD
0.00 (0.00%)
Updated Sep 24, 2024 01:26 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.21 | 0.00% |
Earnings Summary
For their last quarter, Autolus Therapeutics (AUTL) reported earnings of -$0.22 per share, missing the Zacks Consensus Estimate of -$0.19 per share. This reflects a negative earnings surprise of 15.79%. Look out for AUTL's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.21 per share, reflecting a year-over-year increase of 19.23%.
Earnings History
Price & Consensus
Zacks News for AUTL
Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?
AUTL: What are Zacks experts saying now?
Zacks Private Portfolio Services